× |
|
First-Year Medicare Part D Prescription Drug Benefits: Medication Access and Continuity Among Dual Eligible Psychiatric Patients PDF |
$40.00 |
|
$40.00 |
× |
            |
Lack of Effect of Intravenous Immunoglobulins on Tics: A Double-Blind Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
× |
            |
Return to Life PDF |
$40.00 |
|
$40.00 |
× |
            |
Obsessive-Compulsive Disorder Following COVID-19 Infection PDF |
$40.00 |
|
$40.00 |
× |
            |
Cerebellar Cognitive Affective Syndrome: A Case Report PDF |
$40.00 |
|
$40.00 |
× |
            |
COVID-19 and Telepsychiatry in Iran PDF |
$40.00 |
|
$40.00 |
× |
            |
Cognitive Remediation Therapy for Psychotic Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
× |
            |
Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study PDF |
$40.00 |
|
$40.00 |
× |
            |
Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
× |
            |
Converting From Intramuscular to Oral Risperidone in a Nursing Home Resident PDF |
$40.00 |
|
$40.00 |
× |
            |
Psychotic Exacerbation Following Subcutaneous Leuprolide in a Male Patient With Previous History of Schizophrenia PDF |
$40.00 |
|
$40.00 |
× |
            |
Rehabilitation PDF |
$40.00 |
|
$40.00 |
|